|[December 06, 2013]
Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Catalyst Pharmaceutical Partners, Inc.
BENSALEM, Pa. --(Business Wire)--
Law Offices of Howard G. Smith announces that a class action lawsuit has
been filed in the United States District Court for the Southern District
of Florida on behalf of a class (the "Class") comprising all purchasers
of the securities of Catalyst Pharmaceutical Partners, Inc. ("Catalyst"
or the "Company") (NASDAQ:CPRX) between October 31, 2012 and October 18,
2013, inclusive (the "Class Period").
Catalyst is a pharmaceutical company focused on developing and marketing
novel prescription drugs targeting rare neuromuscular and neurological
diseases and disorders. One of the Company's principal products is
Firdapse, currently in Phase III clinical trials for treatment of
Lambert-Eaton (News - Alert) Myasthenic Syndrome (LEMS), a rare autoimmune disease. The
Complaint alleges that defendants failed o disclose that a competitor
company has been manufacturing a drug equivalent to Firdapse, and
providing it to patients with LEMS, free of charge through a
compassionate use program, for the past 20 years. On October 18, 2013,
an article published by TheStreet alleged that Catalyst's
Firdapse is the same drug that its competitor has been manufacturing and
providing in the U.S. for the past 20 years.
If you are a member of the Class described above, you may move the Court
no later than December 24, 2013, to serve as lead plaintiff; however,
you must meet certain legal requirements. To be a member of the Class
you need not take any action at this time; you may retain counsel of
your choice or take no action and remain an absent member of the Class.
If you have any questions concerning this Notice or your rights or
interests with respect to these matters, please contact Howard G. Smith,
Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite
112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll
Free at (888) 638-4847, or by email to email@example.com,
or visit our website at http://www.howardsmithlaw.com.
[ Back To Technology News's Homepage ]